TP73

protein-coding

tumor protein p73

Gene summary

This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined. [provided by RefSeq, Feb 2011]

MANE transcript

NM_005427.4

Inheritance

AR

ClinVar variants

P:5U:96B:23

Top phenotype

Ciliary dyskinesia, primary, 47, and lissencephaly

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chr1:3,652,516-3,736,201

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~83.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

ciliary dyskinesia, primary, 47, and lissencephalySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0030346

Submitter: G2P

ciliary dyskinesia, primary, 47, and lissencephalySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0030346

Submitter: ClinGen

The *TP73* gene encodes a transcription factor belonging to the p53 family and controls cell proliferation and cell death, as well as the architecture and homeostasis of various tissues (PMID: 34368167). *TP73* has been reported as an essential positive regulator of lung ciliated cell differentiation (PMID: 34077761) as well as an activator of FOXJ1 expression (PMID: 26988441). *TP73* was first reported as a candidate gene linked to primary ciliary dyskinesia 47 and lissencephaly in 2021 (Wallmeier et al., PMID: 34077761). The specific disease entity, primary ciliary dyskinesia 47 and lissencephaly (CILD47, MONDO:0030346, OMIM#: 619466), is part of a larger group of more than 40 forms of primary ciliary dyskinesia (PCD) with a monogenic etiology. Autosomal-recessive motile ciliopathy is triggered by loss-of-function variants in *TP73* leading to impaired differentiation of multiciliated cells (MCC). This defect is the underlying cause of a severe, chronic, and destructive pulmonary disease, as well as abnormalities in the development of the cerebral cortex. The 2021 study described seven patients from five non-related families with a history of consanguinity who experienced chronic respiratory conditions affecting both upper and lower airways, characterized by repeated infections, a productive cough, persistent rhinitis, and frequent otitis media (PMID: 34077761). Some patients exhibited these symptoms very early on, with onset in the neonatal period necessitating respiratory support. One patient required medical intervention at two months old due to respiratory failure complications. Chest radiographs indicated conditions such as atelectasis, mucus obstruction, and bronchiectasis. However, there was no occurrence of situs inversus among these individuals. Additionally, these patients had brain irregularities that closely resembled patterns of anterior focused lissencephaly, often accompanied by a thin, poorly developed, or completely absent corpus callosum. These neurological abnormalities were associated with a spectrum of intellectual disabilities, central hypotonia, and evidence of increased seizure susceptibility (PMID: 34077761). Respiratory epithelial cells from patient samples harboring TP73 variants were cultured under an air-liquid interface (ALI) and showed a reduced number of FOXJ1- and RFX2-positive multi-ciliated cells, a reduction in ciliary length, a severe defect in differentiation, and an inability to transport particles by ciliary beating *in vitro* (PMID 34077761). Five suspected disease-causing variants have been scored as part of this curation (one multi-exon deletion, one frameshift, two nonsense, and one canonical splice site disruption introducing a premature stop codon). These variants have been collectively reported in five probands in one publication, all of whom were homozygous for their respective variants (PMID: 34077761). The parents of these individuals were found to be heterozygous carriers of the respective variants. This gene-disease relationship is also supported by experimental evidence. *TP73* expression in humans is found in ciliated-related organ tissue such as the lung and testis (PMID: 24309898). A pooling-based genome-wide association study reported a link between p73 and chronic rhinosinusitis in a human population (PMID: 20211107). Animal models have shown that mice functionally deficient in p73 exhibited profound neurological defects, hydrocephalus, chronic infections, and inflammation. Histologically, the p73-/- mice developed severe rhinitis and purulent otitis media, and massive neutrophil infiltrates of these sites were evident at the earliest ages and persisted through adulthood when greater than 80% of p73-/- mice exhibited chronic, bilateral rhinitis, otitis, periorbital edema, and conjunctivitis (PMID:10716451). The same finding was replicated by Nemajerova et al., 2016 (PMID: 27257214) with similar upper and lower airway phenotypes. A separate mouse model was created, demonstrating that mice deficient in p73 display pronounced airway abnormalities including epithelial hyperplasia, loss of epithelial integrity, and the absence of multiciliated cells (MCC). Additionally, these mice showed clear signs of lung infection and inflammation, including the accumulation of debris, mucus, and inflammatory cells within the bronchioles, leading to crystalline pneumonia (PMID: 26947080). Isolated murine tracheal epithelial cells (MTECs) from these mice demonstrated a significant change in the cellular composition of epithelium from murine tracheas and bronchioles and reduced ciliated cells compared to the wild-type controls. p73 regulates Foxj1 as a transcriptional regulator in multi-ciliogenesis (PMID: 26947080). Finally, a mouse model has recapitulated the neurological feature of immature and aberrant multi-ciliated ependymal cells that persist in adulthood (PMID: 26482843). In summary, *TP73* is strongly associated with primary ciliary dyskinesia 47 and lissencephaly. This has been demonstrated in both clinical diagnostic and research settings without the emergence of contradictory evidence, leading to a strong classification. Replication over a longer period will be required to reach a more definitive gene-disease association. The ClinGen Motile Ciliopathy GCEP approved this classification on September 14, 2023 (SOP Version 10).

ciliary dyskinesia, primary, 47, and lissencephalySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0030346

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Ciliary dyskinesia, primary, 47, and lissencephalyAR

Manifestation: Allergy/Immunology/Infectious; Neurologic; Pulmonary

Intervention: Allergy/Immunology/Infectious; Pulmonary

Rationale: Among other features, the condition can include susceptibilty to respiratory infections and difficulties with mucociliary clearance, and awareness may allow preventative measures and early and aggressive treatment of infections

Refs: 34077761Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to TP73 variants in ClinVar

7 Conditions Cataloged
Inborn genetic diseasesTotal: 103
not providedTotal: 11
Ciliary dyskinesia, primary, 47, and lissencephalyTotal: 10
not specifiedTotal: 6
TP73-related disorderTotal: 3
Neurodevelopmental disorderTotal: 1
Respiratory failureTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005427.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
13
clinvar
3
clinvar
17
missense
93
clinvar
6
clinvar
1
clinvar
100
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
clinvar
1
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
Total4196194124
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 38 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005427.4RefSeqNP_005418.113MANE Select
ENST00000378295.9EnsemblENSP00000367545.413MANE Select
NM_001126240.3RefSeqNP_001119712.112Standard
NM_001126241.3RefSeqNP_001119713.111Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
tp73Danio rerio

Structure: ceratobranchial cartilage

Quality: decreased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Neurotrophin signaling pathway - Homo sapiens (human)
  • p53 signaling pathway - Homo sapiens (human)
  • Hippo signaling pathway - Homo sapiens (human)
  • Measles - Homo sapiens (human)
  • TP53 Network

Biological Process

  • activation of MAPK activity
  • kidney development
  • mismatch repair
  • cellular response to DNA damage stimulus
  • cell cycle arrest

Molecular Function

  • RNA polymerase II proximal promoter sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • p53 binding
  • DNA-binding transcription factor activity

Cellular Component

  • chromatin
  • nucleus
  • nucleoplasm
  • mitochondrion
  • Golgi apparatus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000378295
Coding exons
13
Length
83682
Individuals with no LoFs
125688
Homozygous LoFs
0
Heterozygous LoFs
8
Defined
125696
p
0.0000318
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.853224300.7490.00002804147
Missense (PolyPhen)93167.170.556331520
Synonymous-1.172061861.110.00001351246
Loss of Function4.59330.30.09910.00000156313

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000300.000029rare
Ashkenazi Jewish0.000100.000099rare
East Asian00.0absent
Finnish0.0000460.000046rare
European (Non-Finnish)0.00000890.0000088rare
South Asian0.000130.00013rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. {ECO:0000269|PubMed:10203277, ECO:0000269|PubMed:11753569, ECO:0000269|PubMed:18174154}.;

Recessive Scores

pRec
0.301

Intolerance Scores

LoFtool
0.0179
RVIS EVS
-1.73
RVIS percentile EVS
2.44

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.909

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.